Vertex Pharmaceuticals’ year-to-date stock performance.
CME Group’s year-to-date stock performance.
CME Group: “It is one of the most consistent, great companies…It is a strong buy.”
T. Rowe Price Group’s year-to-date stock performance.
Vertex Pharmaceuticals is a buy